AstraZeneca says it has established more than 20 different supply nodes in parallel supply chains to roll out three billion doses of its COVID-19 vaccine this year. Late last month, the UK became the first jurisdiction to approve the Oxford-AstraZeneca vaccine (AZD1222) in its efforts against COVID-19. Mexico, Brazil and India are among the countries that have since followed suit, while an approval decision from the European Medicines Agency is expected by January 29. The vaccine, which uses the modified…
Tuesday, January 19, 2021 Daily Archives
Cognate pushes on with global expansion project despite COVID
Cognate plans to increase capacity in Europe four-fold and to double existing capacity at its US site. This time last year, Cognate Bioservices completed the acquisition of Cobra Biologics, adding its plasmid and viral vector manufacturing capabilities to its own cell therapy services. Cognate began this year with another announcement, it would be adding to its subsidiary’s manufacturing capacity through an investment in Europe, alongside bolstering its existing facilities in the US. The European expansion will see Cobra quadruple capacity…